Warning: The NCBI web site requires JavaScript to function. more...
Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin.
Falbo A, Rocca M, Russo T, D'Ettore A, Tolino A, Zullo F, Orio F, Palomba S.
J Ovarian Res. 2010 Jul 21;3:16.
Related citations
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
Palomba S, Falbo A, Russo T, Orio F, Tolino A, Zullo F.
Hum Reprod. 2010 Apr;25(4):1005-13. Epub 2010 Jan 26.
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
Das M, Gillott DJ, Saridogan E, Djahanbakhch O.
Hum Reprod. 2008 Sep;23(9):2122-6. Epub 2008 Jun 10.
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I.
Hum Reprod. 2009 Nov;24(11):2917-23. Epub 2009 Jul 18.
Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
Diamanti-Kandarakis E, Piouka A, Livadas S, Piperi C, Katsikis I, Papavassiliou AG, Panidis D.
Eur J Endocrinol. 2009 May;160(5):847-53. Epub 2009 Feb 10.
Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
Carlsen SM, Vanky E, Fleming R.
Hum Reprod. 2009 Jul;24(7):1732-8. Epub 2009 Apr 2.
Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D.
J Clin Endocrinol Metab. 2003 Dec;88(12):5957-62.
Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis.
Falbo A, Orio F, Venturella R, Rania E, Materazzo C, Tolino A, Zullo F, Palomba S.
J Ovarian Res. 2009 May 31;2:5.
Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
J Clin Endocrinol Metab. 2007 May;92(5):1871-4. Epub 2007 Feb 13.
Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.
Tomova A, Deepinder F, Robeva R, Kirilov G, Mechandjiev Z, Kumanov P.
Horm Metab Res. 2011 Sep;43(10):723-7. Epub 2011 Sep 19.
The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN.
Hum Reprod. 2008 Apr;23(4):952-7. Epub 2008 Feb 6.
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ.
Fertil Steril. 2007 Apr;87(4):870-5. Epub 2007 Jan 16.
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D, Georgopoulos NA, Piouka A, Katsikis I, Saltamavros AD, Decavalas G, Diamanti-Kandarakis E.
Gynecol Endocrinol. 2011 Aug;27(8):587-92. Epub 2010 Sep 14.
Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.
J Clin Endocrinol Metab. 2004 Jan;89(1):318-23.
Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
Somunkiran A, Yavuz T, Yucel O, Ozdemir I.
Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):196-201. Epub 2007 Mar 1.
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.
Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC.
Hum Reprod. 2004 Sep;19(9):2036-42. Epub 2004 Jun 24.
Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.
Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E238-43. Epub 2008 Oct 28.
The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
Fábregues F, Castelo-Branco C, Carmona F, Guimerá M, Casamitjana R, Balasch J.
Gynecol Endocrinol. 2011 Apr;27(4):216-24. Epub 2010 May 26.
Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?
Carmina E, Longo A, Lobo RA.
Am J Obstet Gynecol. 2003 Nov;189(5):1283-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on